In the second episode of the Cancer Nurses Society of Australia podcast series, we discuss Antibody- Drug Conjugates (ADCs). ADCs are a new type of cancer treatment that combines the targeting ability of antibodies with the potency of chemotherapy drugs.
As oral therapies become central in ovarian cancer care, cancer nurses are key to optimising patient outcomes through proactive monitoring and side effect management.
The fifth session in CNSA’s Cancer Nursing 101 series focused on Targeted Therapies—what they are, how they work, and the key role of nurses in supporting patients receiving these treatments. Build your understanding of drug types, side effects, and practical nursing care in this essential webinar.
